PGR and cancer: All NSAID consumption was protective for hormone receptor + cancer (i.e.: ER+ or PR+) (OR = 0.72; 95 % CI: 0.60–0.88) and HER2+ cancers (OR = 0.63; 95 %: 0.45–0.88).